Metformin Hydrochloride
- Product NDC
- 72336-095
- 11-digit product format
- 723360095
- Labeler code
- 72336
- Product ID
- 72336-095_2cda4edb-3ee7-0035-e063-6294a90a7800
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metformin Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lifsa Drugs, LLC
- Application
- ANDA075972
- Marketing category
- ANDA
- Marketing start
- 2002-01-24
- Substance
- METFORMIN HYDROCHLORIDE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Biguanide [EPC], Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metformin Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METFORMIN HYDROCHLORIDE | 750 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 786Z46389E |
| Rxcui | 861021, 2703582 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72336-095-30 | Metformin Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72336-095 | METFORMIN HYDROCHLORIDE TABLET [LIFSA DRUGS, LLC] | 3 | Current NDC, 1 package rows | 20250130_a2385bcd-0943-4411-8658-c22b50360385.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72336-095-30 | 72336009530 | 30 TABLET in 1 BOTTLE (72336-095-30) | 30 tablet | 2025-01-23 | No | No | Historical |